To determine the cause of an unprecedented outbreak of encephalitis among horses in New South Wales, Australia, in 2011, we performed genomic sequencing of viruses isolated from affected horses and mosquitoes. Results showed that most of the cases were caused by a variant West Nile virus (WNV) strain, WNV NSW2011 , that is most closely related to WNV Kunjin (WNV KUN ), the indigenous WNV strain in Australia. Studies in mouse models for WNV pathogenesis showed that WNV NSW2011 is substantially more neuroinvasive than the prototype WNV KUN strain. In WNV NSW2011 , this apparent increase in virulence over that of the prototype strain correlated with at least 2 known markers of WNV virulence that are not found in WNV KUN . Additional studies are needed to determine the relationship of the WNV NSW2011 strain to currently and previously circulating WNV KUN strains and to confi rm the cause of the increased virulence of this emerging WNV strain.
I
n Australia, Murray Valley encephalitis virus (MVEV) and West Nile virus (WNV) Kunjin (KUN) strain are the main etiologic agents of arboviral encephalitis in humans, which usually occurs as isolated sporadic cases or occasional small outbreaks, mainly in northwestern Australia and rarely in southern regions ( Figure 1 , panel A) (1) . MVEV is the more virulent pathogen and the only proven cause of fatal arboviral encephalitis in humans in Australia (2) . WNV KUN infections are infrequent and less severe (3) . Horses are also susceptible to these viruses and have been involved in WNV outbreaks elsewhere, most notably in the United States in an outbreak that began in 1999. In Australia, infection with WNV KUN has been detected intermittently in horses in the Southeast, but reports of encephalitis caused by this virus are rare (3) . In New South Wales (NSW), Australia, the seroprevalence of WNV KUN in horses is <5% (P.D. Kirkland and A. Read, unpub. data); infection is confi ned to inland areas where fl ooding supports large mosquito populations and water birds are a reservoir and amplifying host. Even in years when WNV KUN has caused disease in humans, disease has rarely been observed or confi rmed in horses (3, 4) .
In 2011, an outbreak of encephalitis occurred among horses in NSW. To analyze this strain of WNV KUN , we conducted genomic sequencing, antigenic profi ling, in vitro growth kinetics, and mouse virulence studies on virus isolates from diseased animals and mosquitoes.
Materials and Methods

Disease Outbreak
In late February 2011, neurologic disease was reported in several horses in northwestern and southwestern NSW. The number of cases and geographic distribution gradually increased. By mid-June 2011, specimens from ≈300 horses were submitted to the virology laboratory at Elizabeth Macarthur Agriculture Institute (Menangle, NSW, Australia). Many more horses probably were affected.
Diseased horses were located throughout most of NSW, west of the Great Dividing Range, but also extending through the Hunter River Valley region, Sydney Basin, and Illawarra coastal region immediately south of Sydney ( Figure 1, panel B) . Cases also occurred in other southern Australia states. Clinical signs were generally consistent with those described in horses infected with WNV in the United States (5) . A detailed report of the clinical signs, virology, and pathology of equine cases will be published elsewhere.
Specimen Collection
Whole brains were removed from 12 horses at postmortem examination. Half of each brain was fi xed in 10% neutral buffered formalin; the other half was held fresh at 4°C. Upon receipt, we collected small pieces of fresh and formalin-fi xed tissue from several locations in the cerebrum and cerebellum and along the brain stem and cervical spinal cord. If virus isolation could not be performed on fresh samples within 24 h after receipt, we held the samples at −80°C until tested. Before testing, we prepared 10% tissue homogenates in RPMI medium (Life Technologies, Carlsbad, CA, USA) containing antimicrobial drugs.
Mosquitoes were collected throughout NSW, as part of the NSW Arbovirus Surveillance and Mosquito Monitoring Program, by using dry ice-baited light traps. The mosquitoes were submitted live to the Medical Entomology Laboratory at Westmead Hospital (Westmead, NSW, Australia) for species identifi cation, arbovirus isolation, and virus identifi cation (6).
Cells and Viruses
We propagated Vero 76 cells in Dulbecco modifi ed minimum essential medium (DMEM; Life Technologies) supplemented with 10% fetal bovine serum (FBS). C6/36 Aedes albopictus mosquito cells were maintained in RPMI medium supplemented with 10% FBS, and BHK21 cells were maintained in DMEM containing 5% FBS. All cell lines were obtained from the American Type Culture Collection (Manassas, VA, USA). We used prototype WNV KUN MRM61C (7) and WNV New York 99 (WNV NY99 ) 4132 strains (8) 
Virus Neutralization Tests
We conducted microneutralization tests (9) in Vero cells by using 25-100 infectious units (measured as 50% tissue culture infective doses) of WNV NSW2011 , WNV KUN , and WNV NY99 ; we used 2-fold dilutions of serum from an initial dilution of 1:20. Results were scored as 80% reduction in virus growth or 100% inhibition of virus growth. Reduction in virus growth was determined by assessing the extent of cytopathic effect in each well. Inhibition of virus growth was determined by the absence of viral antigen in the cells of each well when tested with a WNV-reactive monoclonal antibody (mAb) in ELISA. 
Nucleic Acid Purifi cation
We used the MagMax-96 Viral RNA Isolation Kit (Ambion, Austin, TX, USA) on a magnetic particle handling system (Kingfi sher 96; Thermo Electron Corporation, Vantaa, Finland) to extract total nucleic acid from clarifi ed 10% brain homogenate (50 μL) or tissue culture fl uid. Purifi ed nucleic acids were eluted in 50 μL of kit elution buffer and used immediately for PCR amplifi cation or stored frozen at ≈−20°C
Real-Time Reverse Transcription PCR
We used a published WNV real-time reverse transcription PCR (rRT-PCR) (10 [assay 2]) with the following variations: Black Hole Quencher (Biosearch Technologies, Novato, CA, USA) was used instead of TAMRA on the probe, the internal control system was not used, and 5 μL of RNA was used as template. The AgPath-ID One-Step RT-PCR Kit (Applied Biosystems, Foster City, CA, USA) was used for the rRT-PCR on a 7500HT Fast Real-Time PCR System (Applied Biosystems). We ran rRT-PCR reactions in standard mode, according to conditions recommended by the mastermix manufacturer.
Virus Isolation
Supernatant from the 10% brain homogenate was placed on monolayers of A. albopictus C6/36 mosquito cells in cell culture tubes. The cultures, which were maintained in RPMI medium containing antimicrobial drugs at standard concentrations and supplemented with 2% FBS, were incubated at 28°C for 5-7 days. Culture supernatants were then passaged up to 3× on BHK21 cells maintained in Basal Medium Eagle (MP Biomedicals, Sydney, Australia) containing antimicrobial drugs and 2% FBS. We regularly examined cultures by light microscopy for cytopathic effects. We used rRT-PCR to confi rm the identity of virus isolates in culture supernatants or to confi rm that there was no virus replication in the absence of cytopathology. Viral RNA recovered from culture fl uid at the fi rst or second passage in BHK21 cells was sequenced as described below. A virus isolate obtained from the fi rst brain examined was designated WNV NSW2011 . Virus isolation was conducted on homogenates of mosquitoes by similar methods but with passage onto BHK and PSEK cells after initially being placed on C6/36 cells. We identifi ed virus isolates by using immunoassays with generic and specifi c mAbs.
WNV NSW2011 virus harvested from the fi rst passage in C6/36 cells was used to examine plaque morphology and virulence in mice. The virus was passaged 1× in Vero76 cells for 4 d and 1× in C6/36 cells for 5 d. Virus supernatant was centrifuged at 500 × g at 4°C for 5 min before being stored at −80°C
Reactivity with mAbs
Reactivity of the new isolate with a panel of mAbs was compared with that of WNV KUN and WNV NY99 by using a fi xed-cell ELISA (11) . The mAbs and their characteristics follow: mAb 10C6, anti-nonstructural protein (NS) 1 (reactive with MVEV); mAb 10A1, antienvelope glycoprotein (anti-E; specifi c for WNV KUN ); mAb 2B2, anti-E (reactive with WNV); mAb 3.1112G, anti-NS1 (reactive with WNV); mAb 5H1, anti-NS5 (strong reaction with WNV KUN strains, weak for WNV NY99 , nonreactive with WNV strains from other lineages); mAb 17D7, anti-E (specifi c for strains of WNV with glycosylated E); mAb 3.101C, anti-E (specifi c for strains of WNV with unglycosylated E); and the pan-fl avivirus-reactive mAbs (i.e., 4G4, anti-NS1; and 4G2, anti-E) (12-15; J. HobsonPeters et al., unpub. data).
Nucleic Acid Sequencing
For sequencing of the whole genome, we used total nucleic acid purifi ed from virus-infected cell culture supernatant as template in 5 RT-PCRs with primers designed to cover the coding regions of any WNV genome (Table 1) . RT and amplifi cation were performed by using the SuperScript III One-Step RT-PCR System (Invitrogen, Carlsbad, CA, USA) with primers at 20 μM. RT was performed at 50°C for 30 min, followed by denaturation at 94°C for 2 min. PCR amplifi cation involved 40 cycles (95°C for 30 s, 55°C for 1 min, 68°C for 4.5 min) followed by a fi nal extension at 68°C for 10 min. Reaction products were visualized after electrophoresis on a ethidium bromide-stained 1% agarose gel. Reaction products were purifi ed directly (MinElute PCR Purifi cation Kit; QIAGEN, Valencia, CA, USA) or excised from the gel and cleaned (Gel MinElute PCR Purifi cation Kit; QIAGEN). Purifi ed nucleic acid was sequenced at the Australian Genome Research Facility (Sydney) by using the primers used to generate the PCR product. Each RT-PCR was run 3× and sequenced in both forward and reverse orientation. Sequence data were assembled by using Sequencher software (Gene Codes Corp., Ann Arbor, MI, USA). For subsequent isolates from horses and mosquitos, we used primers designed from the sequence of the WNV NSW2011 genome (Table 1 ) to amplify and sequence the NS3 and NS5 regions, in which changes had been identifi ed. The same RT-PCR and sequencing methods were used, except that the annealing temperature was 50°C and extension time was 1 min. The nucleic acid sequences were translated and then aligned with WNV NSW2011 and WNV KUN (GenBank accession nos. JN887352 and D00246.1, respectively) by using ClustalW (www.clustal.org).
Bioinformatics Analysis
Complete coding regions of selected WNV isolates, representing all lineages and clades and including all complete KUN sequences, were aligned with the WNV NSW2011 sequence as described (16) . This alignment was transferred to BioEdit (www.mbio.ncsu.edu/BioEdit/ bioedit.html) for manual editing before construction of phylogenetic trees. Maximum-likelihood trees were constructed by using PhyML (17) . Trees were rooted by using the Japanese encephalitis virus Nakayama sequence (GenBank accession no. EF571853), which was removed from the fi nal tree for clarity.
Endoglycosidase Digestion
To examine glycosylation of the E protein, viral proteins from cultures of infected C6/36 cells were digested as described (18) . Proteins were separated and analyzed by Western blot. Samples were loaded with reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis buffer (NuPAGE LDS Sample Buffer; Invitrogen) on a 4%-12% NuPAGE Gel (Invitrogen). Electrophoresed proteins were electroblotted onto nitrocellulose paper (Hybond C; GE Healthcare, Little Chalfont, UK) and immunostained with anti-E mAb (11).
Plaque Morphology
We allowed the virus to adsorb to monolayers of Vero 76 cells in 6-well plates for 2 h at 37°C. The cells were overlaid with DMEM containing 0.75% low melting point agarose and 2% FBS. Four days after infection, the cells were fi xed with 4% formaldehyde solution and stained with 0.2% crystal violet.
Virulence in Mice
Groups of 10 weanling (18-19 days old) or young adult (4 weeks old) Swiss outbred CD1 mice were injected intraperitoneally with 10-fold dilutions of virus. The mice were monitored for 21 days after injection and euthanized when signs of encephalitis were evident. All animal procedures had received prior approval from The University of Queensland Animal Ethics Committee. 
Results
Virus Isolation and Initial Characterization
Antigenic Analysis of WNV NSW2011
To antigenically type WNV NSW2011 in a fi xed-cell ELISA (11), we used a panel of mAbs previously shown to differentiate between strains of WNV KUN and other WNVs (11, (13) (14) (15) 19, 20) . The recognition patterns showed that the WNV NSW2011 isolate most closely resembled Australian WNV KUN strains; the WNV KUN -specifi c mAb 10A1 reacted strongly with prototype WNV KUN and WNV NSW2011 but not with WNV NY99 (Table 2) . However, the anti-NS5 mAb 5H1, which is also specifi c for WNV KUN isolates from Australia (15), failed to react with WNV NSW2011 and WNV NY99 , but it bound strongly to WNV KUN . The reaction patterns of mAbs 17D7 and 3.101C, which react specifi cally with glycosylated and unglycosylated WNV E antigens, respectively (11,14; J. Hobson-Peters et al., unpub. data), indicated that, unlike the E protein of WNV KUN , the E protein of WNV NSW2011 is glycosylated.
To assess the level of antigenic crossreactivity between WNV NSW2011 , WNV KUN , and WNV NY99 , we assessed neutralization titers for homologous and heterologous viruses in immune serum samples from the following sources: horses infected during the 2011 outbreak, horses infected with WNV KUN in the Northern Territory of Australia several years earlier, and horses infected with WNV in the United States. Convalescent-phase serum samples from WNV NSW2011 -immune horses had neutralizing titers similar to those of the homologous virus (WNV NSW2011 ) and of WNV KUN and WNV NY99 (Table 3) . Serum samples from WNV KUN -immune horses from Northern Territory and from WNV-immune animals from the United States showed a similar pattern of cross-neutralization. However, serum samples from horses from Northern Territory and the United States showed slightly less neutralizing effi ciency of WNV NSW2011 ; this was likely due to a higher dose (≈4-fold) of virus in the assay (Table 3) . Overall, these results are consistent with those in our previous reports showing a high level of cross-neutralization between WNV KUN and WNV NY99 strains (21, 22) .
Nucleotide and Amino Acid Sequence Analysis of WNV NSW2011
A comparison of the nucleotide sequence of the complete coding region of the fi rst isolate of WNV NSW2011 with sequences available in GenBank confi rmed that WNV NSW2011 was genetically most closely related to Australian WNV KUN isolates (Figure 2 1  <20  <20  <20  <20  <20  <20  2  <20  <20  <20  <20  <20  <20  3  <20  <20  <20  <20  <20  <20  4  <20  <20  <20  <20  <20  <20  5  <20  <20  <20  <20  <20  <20  NSW#  04  640  320  1,280  1,280  640  320  06  320  160  640  640  1,280  160  08  320  320  1,280  1,280  640  640  28  320  320  640  640  320  320  36  320  160  640  640  320 Appendix Table) . The glycosylation tripeptide (N-Y-S) at residues E 154-156 , which allows N-linked glycosylation at a conserved site on the E protein, domain I, and is associated with virulence in most WNV strains (23) , was present in WNV NSW2011 ; its presence is consistent with the mAb recognition profi le. A phenylalanine residue at aa 653 in NS5, which also is associated with enhanced virulence of WNV strains (24) , was present in WNV NSW2011 . Because the WNV KUN strain-specifi c mAb 5H1 did not react with WNV NSW2011 , we also examined the predicted amino acid sequence of the NS5 protein that corresponded to the linear epitope previously mapped for 5H1 to residues 41-53 in the methyltransferase domain (15) . WNV NSW2011 and WNV NY99 contain a substitution (I-V) at residue 49 that is not contained in WNV KUN , confi rming the critical role of this residue for 5H1 binding. Together these data suggest that WNV NSW2011 represents a virulent WNV strain that has emerged in Australia. However, the amino acid substitution in NS3, which is believed to be associated with increased virulence of WNV NY99 in birds in North America (25) , was not present in isolate WNV NSW2011 . Sequencing of the key regions of the other WNV isolates obtained during this outbreak (3 from horses and 8 from mosquitoes) showed that each was indistinguishable from WNV NSW2011 .
In vitro Growth Properties and E Protein Glycosylation Status of WNV NSW2011
The average plaque size of WNV NSW2011 (Figure 3 , panel A) was 4.2 mm ± 0.5 mm, much closer to WNV NY99 (4.7 mm ± 0.8 mm) than to the prototype WNV KUN (2.8 mm ± 0.4 mm). To confi rm the presence of an N-linked glycan on the E protein of WNV NSW2011 , we used Western blot to analyze endoglycosidase-digested viral protein. Analysis showed that the E protein of WNV NSW2011 and WNV NY99 migrated slightly faster than the undigested control protein. This result is consistent with N-linked glycosylation (Figure 3, panel B) . However, consistent with the lack of a potential glycosylation site on the E protein of most WNV KUN isolates, we found no evidence of N-linked glycosylation for WNV KUN (11, 20, 26) .
Neuroinvasive Properties of WNV NSW2011 in mice
Injection of 18-to 19-day-old (weanling) mice with 10-fold dilutions of virus showed that substantially lower doses of WNV NSW2011 (50% lethal dose [LD 50 ] 0.5 PFU), compared with WNV KUN (LD 50 13.4 PFU), induced neurologic signs (Table 4) ; and the time to disease onset was substantially shorter (Table 4 ; Figure 3 , panel C). In contrast, the LD 50 for WNV NY99 (0.1 PFU) was lower than that for WNV NSW2011 , and neurologic signs developed more rapidly (Table 4 ; Figure 3 , panel C). Only WNV NY99 and WNV NSW2011 caused a substantial number of deaths among 4-week-old (young adult) mice. Compared with WNV NSW2011 , WNV NY99 exhibited a lower LD 50 (240 PFU vs. 0.7 PFU, respectively) and a shorter time to death (10.7 days vs. 6.6 days, respectively, at 1,000 PFU) (Table 5 ; Figure 3 , panel C).
Discussion
It is estimated that at least 1,000 horses were affected during an unprecedented outbreak of encephalitis in southeastern Australia during 2011. The case-fatality rate was 10%-15%, and diseased animals had clinical signs consistent with those observed during a WNV outbreak in the United States. Not only was the Australian outbreak unique and unprecedented in size and disease severity, but its epidemiologic features also differed from those prototype strain of WNV KUN , which might explain the severity of the 2011 outbreak. However, the association between the identifi ed and perhaps other amino acid changes and increased virulence of WNV NSW2011 in horses and mice will require further confi rmation by using sitedirected mutagenesis of an infectious cDNA clone. Another unusual aspect of the 2011 outbreak was the absence of encephalitis caused by WNV KUN in humans. In contrast, several confi rmed cases of Murray Valley encephalitis in humans were recorded in southeastern Australia during this time. This absence of disease in humans suggests that ecologic and/or epidemiologic features of the virus transmission cycle, such as small mosquito populations and timely alerts, probably resulted in less exposure of the human population to WNV NSW2011 .
The US outbreak of WNV was associated with high mortality among several bird species, particularly American crows (Corvus brachyrhynchos). In contrast, increased mortality among birds of any species was not reported during the 2011 outbreak in southeastern Australia. The lack of disease in birds in Australia supports the hypothesis that the amino acid substitution observed in WNV NY99 (Ala-Pro at aa 249 in NS3) (25) is associated with increased virulence in birds because this change was not present in the WNV NSW2011 isolate. However, this observation should be viewed with some caution because of the species differences between birds in Australia and the United States and because disease was limited or absent when a species of Australian crow (Little Raven [Corvus mellori]) was experimentally infected with WNV NY99 (28) .
Taken together, our results show that the WNV NSW2011 isolate is closely related to Australian WNV KUN strains. However, in contrast to the prototype WNV KUN strain (MRM-61C), the new virus has several amino acid substitutions that are likely to be the reason for enhanced virulence in horses. More extensive epidemiologic studies in the fi eld and experimental studies in the laboratory are required to determine the relation of WNV NSW2011 to other currently and previously circulating WNV KUN strains and to confi rm which viral proteins and amino acid residues are associated with increased virulence of WNV NSW2011 in horses. 
